recent technologies and research me...

recent technologies and research methods aim to abridge study failures and incitement drug development.
The diet and Drug Administration unveiled a report in March that aims to stimulate fresh thinking about how to reverse new biomedical discoveries into sale and effective therapies more quickly and more efficiently. A main objective is to overset the recent decline in modern drug applications (NDAs) filed with the agency, especially for innovative treatments. Former FDA commissioner Mark McClellan often lamented the lag between gains in genomic and other cutting-edge biomedical